메뉴 건너뛰기




Volumn 220, Issue 4, 2010, Pages 370-375

Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma

Author keywords

Bexarotene; Cutaneous T cell lymphoma; T cell clone

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; TETRALIN DERIVATIVE;

EID: 77954241938     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000305354     Document Type: Article
Times cited : (15)

References (18)
  • 1
    • 0036280764 scopus 로고    scopus 로고
    • Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: A possible mechanism for the accumulation of malignant T lymphocytes in the skin
    • Dereure O, Levi E, Vonderheid EC, Kadin ME: Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002; 118: 949-956.
    • (2002) J Invest Dermatol , vol.118 , pp. 949-956
    • Dereure, O.1    Levi, E.2    Vonderheid, E.C.3    Kadin, M.E.4
  • 2
    • 0032212221 scopus 로고    scopus 로고
    • Prognostic significance of polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides
    • Delfau-Larue MH, Dalac S, Lepage E, Petrella T, Wechsler J, Farcet JP, Bagot M: Prognostic significance of polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 1998; 92: 3376-3380.
    • (1998) Blood , vol.92 , pp. 3376-3380
    • Delfau-Larue, M.H.1    Dalac, S.2    Lepage, E.3    Petrella, T.4    Wechsler, J.5    Farcet, J.P.6    Bagot, M.7
  • 3
    • 0034329353 scopus 로고    scopus 로고
    • Diagnostic value of dominant Tcell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma
    • Delfau-Larue MH, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M, Bagot M, Farcet JP: Diagnostic value of dominant Tcell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000; 96: 2987-2992.
    • (2000) Blood , vol.96 , pp. 2987-2992
    • Delfau-Larue, M.H.1    Laroche, L.2    Wechsler, J.3    Lepage, E.4    Lahet, C.5    Asso-Bonnet, M.6    Bagot, M.7    Farcet, J.P.8
  • 4
    • 0042964834 scopus 로고    scopus 로고
    • Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome
    • Kim YH, Liu HL, Mraz-Gernhard S, et al: Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome. Arch Dermatol 2003; 139: 857-866.
    • (2003) Arch Dermatol , vol.139 , pp. 857-866
    • Kim, Y.H.1    Liu, H.L.2    Mraz-Gernhard, S.3
  • 5
    • 0035340844 scopus 로고    scopus 로고
    • Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous t-cell lymphoma: Multinational phase II-III trial results
    • Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, et al: Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 2001; 19: 2456-2471. (Pubitemid 32391217)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.9 , pp. 2456-2471
    • Duvic, M.1    Hymes, K.2    Heald, P.3    Breneman, D.4    Martin, A.G.5    Myskowski, P.6    Crowley, C.7    Yocum, R.C.8
  • 6
    • 0034999546 scopus 로고    scopus 로고
    • Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma
    • Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA: Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 2001; 137: 581-593.
    • (2001) Arch Dermatol , vol.137 , pp. 581-593
    • Duvic, M.1    Martin, A.G.2    Kim, Y.3    Olsen, E.4    Wood, G.S.5    Crowley, C.A.6
  • 7
    • 0036096774 scopus 로고    scopus 로고
    • Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action
    • Zhang C, Hazarika P, Ni X, Weidner D, Duvic M: Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res 2002; 8: 1234-1240.
    • (2002) Clin Cancer Res , vol.8 , pp. 1234-1240
    • Zhang, C.1    Hazarika, P.2    Ni, X.3    Weidner, D.4    Duvic, M.5
  • 10
    • 20844443468 scopus 로고    scopus 로고
    • WHOEORTC classification for cutaneous lymphomas
    • Willemze R, Jaffe ES, Burg G, et al: WHOEORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
    • (2005) Blood , vol.105 , pp. 3768-3785
    • Willemze, R.1    Jaffe, E.S.2    Burg, G.3
  • 11
    • 4644340662 scopus 로고    scopus 로고
    • Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series
    • Singh F, Lebwohl MG: Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series. J Am Acad Dermatol 2004; 51: 570-573.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 570-573
    • Singh, F.1    Lebwohl, M.G.2
  • 12
    • 35848945451 scopus 로고    scopus 로고
    • Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides
    • Lokitz ML, Wong HK: Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides. Photodermatol Photoimmunol Photomed 2007; 23: 255-257.
    • (2007) Photodermatol Photoimmunol Photomed , vol.23 , pp. 255-257
    • Lokitz, M.L.1    Wong, H.K.2
  • 15
    • 0041307312 scopus 로고    scopus 로고
    • Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy
    • Ferenczi K, Yawalkar N, Jones D, Kupper TS: Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Arch Dermatol 2003; 139: 909-913.
    • (2003) Arch Dermatol , vol.139 , pp. 909-913
    • Ferenczi, K.1    Yawalkar, N.2    Jones, D.3    Kupper, T.S.4
  • 16
    • 40649110333 scopus 로고    scopus 로고
    • TCRgamma-chain gene rearrangement by PCR-based Gene-Scan: Diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples
    • Ponti R, Fierro MT, Quaglino P, Lisa B, Paola FC, Michela O, Paolo F, Comessatti A, Novelli M, Bernengo MG: TCRgamma-chain gene rearrangement by PCR-based Gene-Scan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol 2008; 128: 1030-1038.
    • (2008) J Invest Dermatol , vol.128 , pp. 1030-1038
    • Ponti, R.1    Fierro, M.T.2    Quaglino, P.3    Lisa, B.4    Paola, F.C.5    Michela, O.6    Paolo, F.7    Comessatti, A.8    Novelli, M.9    Bernengo, M.G.10
  • 17
    • 0032722756 scopus 로고    scopus 로고
    • Durable loss of malignant T-cell clone in stage IV cutaneous T-cell lymphoma patient treated with high dose interferon and photopheresis
    • Haley HR, Davis DA, Sams WM: Durable loss of malignant T-cell clone in stage IV cutaneous T-cell lymphoma patient treated with high dose interferon and photopheresis. J Am Acad Dermatol 1999; 41: 880-883.
    • (1999) J Am Acad Dermatol , vol.41 , pp. 880-883
    • Haley, H.R.1    Davis, D.A.2    Sams, W.M.3
  • 18
    • 34249093850 scopus 로고    scopus 로고
    • Apoptotic responses to alltrans retinoic acid of Targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sézary syndrome
    • Newton SB, Yoon JS, Benoit BM, Wysocka M, Rook AH: Apoptotic responses to alltrans retinoic acid of Targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sézary syndrome. Arch Dermatol 2007; 143: 661-662.
    • (2007) Arch Dermatol , vol.143 , pp. 661-662
    • Newton, S.B.1    Yoon, J.S.2    Benoit, B.M.3    Wysocka, M.4    Rook, A.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.